The overall activation of the PI3K/AKT pathway in ccRCC is higher than in other cancers, suggesting that dysregulation of the PI3K/AKT pathway in RCC may be a consequence of EV-mediated epigenetic mechanisms [47,50]. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.